Product ID:1025/1038 BLACK DRY INK PLUS, 6R500 (XCI)
MSDS Date:12/13/1988
FSC:6850
NIIN:00N016484
MSDS Number: BKRXS

XEROX CORPORATION

100 CLINTON AVE S
ROCHESTER, NY 14644
US

Emergency Phone: 716-422-2177

Info Phone: 800-828-6571

Cage: 26921

XEROX CORPORATION

ROCHESTER, NY 14644-1877 US

Telephone: 800-828-6571/716-422-2177

Cage: 26921

STYRENE, ACRYLATE POLYMER

CAS: 25213-39-2

Fraction By Weight: 60-65%

ACRYLIC RESIN

Fraction By Weight: 20-25%

CARBON BLACK

CAS: 1333-86-4

RTECS: FF5800000

Fraction By Weight: 10-15%

OSHA PEL 3.5 MG/M3

ACGIH TLV: 3.5 MG/M3; 9192

PROPENE POLYMERS (POLYOLEFIN)

CAS: 9003-07-4

RTECS: UD1842000

Fraction By Weight: <10%

AMORPHOUS SILICA

CAS: 7631-86-9

Fraction By Weight: <1%

OSHA PEL 6 MG/M3

ACGIH TLV: 10 MG/M3 TDUST

LD50 LC50 Mixture:LD50:(ORAL RAT)>5 G/KG
Routes of Entry: Inhalation:YES Skin:NO Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INHAL:MINIMAL RESP TRACT IRRIT MAY
OCCUR AS W/EXPOS TO LGE AMTS OF ANY NON-TOX DUST. EYE:NOT AN IRRIT.
SKIN. NOT AN IRRIT. NOT A SENSITIZER. IN A XEROX SPONSORED CHRONIC
INHAL STUDY IN RATS USING A SP EC TEST TONER, THERE WERE NO LUNG
CHANGES AT ALL IN THE LOWEST EXPOS LEVEL (1MG/M3), THE MOST (SEE
EFTS OF OVEREXP)
Explanation of Carcinogenicity:NOT RELEVANT.
Effects of Overexposure:HLTH HAZ:RELEVANT LEVEL TO POTENTIAL HUMAN
EXPOS. A VERY SLIGHT DEGREE OF FIBROSIS WAS NOTED IN 25% OF THE
ANIMALS AT THE MIDDLE EXPOS LEVEL (4 MG/M3) WHILE A SLIGHT DEGREE
OF FIBROSIS WAS OBSERVED AT THE HIGHEST EXPOS LEVEL (16 MG/M3) IN
ALL ANIMALS. THESE FINDINGS ARE ATTRIBUTED TO "LUNG OVERLOADING",
(SEE SUPP DATA)
Medical Cond Aggravated by Exposure:NONE WHEN USED AS DESCRIBED BY
PRODUCT LITERATURE.

First Aid:EYE: FLUSH W/WATER FOR AT LEAST 15 MINUTES. SKIN: WASH W/SOAP
& WATER. INHAL: REMOVE FROM EXPOSURE. INGEST: DILUTE STOMACH
CONTENTS W/SEVERAL GLASSES OF WATER.

Extinguishing Media:WATER, FOAM & DRY CHEMICAL.
Fire Fighting Procedures:WEAR NIOSH/MSHA APPROVED SCBA & FULL
PROTECTIVE EQUIPMENT . AVOID INHALATION OF SMOKE.
Unusual Fire/Explosion Hazard:TONER IS A COMBUSTIBLE POWDER. WHEN
DISPERSED IN AIR, IT CAN FORM EXPLOSIVE MIXTURES.

Spill Release Procedures:LOOSE TONER CAN BE REMOVED USING A VACUUM
CLEANER. RESIDUE CAN BE REMOVED W/SOAP & COLD WATER. AFTER REMOVAL
OF LOOSE TONER, GARMENTS MAY BE WASHED OR DRY-CLEANED.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.

Handling and Storage Precautions:NONE SPECIFIED BY MANUFACTURER.
Other Precautions:AVOID PROLONGED INHALATION OF EXCESSIVE DUST.

Respiratory Protection:NONE REQUIRED WHEN USED AS INTENDED IN XEROX
EQUIPMENT.
Ventilation:NONE SPECIFIED BY MANUFACTURER.
Protective Gloves:NONE REQUIRED.
Eye Protection:NONE REQUIRED.
Other Protective Equipment:FOR USE OTHER THAN NORM CUSTOMER-OPERATING
PROC (SUCH AS BULK TONER PROCESSING FACILITIES) GOGGS/RESPS MAY BE
REQD.
Work Hygienic Practices:NONE SPECIFIED BY MANUFACTURER.
Supplemental Safety and Health
EFTS OF OVEREXP:A GENERIC RESPONSE TO EXCESSIVE AMTS OF ANY DUST
RETAINED IN THE LUNGS FOR A PRLNGD INTERVAL. THE SPEC TEST TONER
WAS TEN TIMES MORE RESPIRABLE THAN COMMERCIALLY AVAIL XEROX TONER
TO C OMPLY W/EPA TESTING PROTOCOL AND WOULD FUNCTION PROPERLY IN
XEROX EQUIPMENT.

HCC:N1
Spec Gravity:1 (H*2O=1)
Solubility in Water:NEGLIGIBLE
Appearance and Odor:BLACK POWDER/FAINT ODOR

Stability Indicator/Materials to Avoid:YES
NONE
Stability Condition to Avoid:NONE SPECIFIED BY MANUFACTURER.
Hazardous Decomposition Products:PRODUCTS OF COMBUSTION ARE TOXIC.
AVOID BREATHING SMOKE.

Waste Disposal Methods:DO NOT INCINERATE. NO SPECIAL TECHNIQUES BEYOND
NORMAL PRACTICE. INSURE CONFORMITY W/FEDERAL, STATE AND LOCAL
REGULATIONS.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.